| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jenny Herman | CAO | 2026-02-10 | 752 | $13.79 | $10.37kSell |
| Yvonne Tran | EVP CLO CPO | 2026-02-10 | 776 | $13.80 | $10.71kSell |
| Kenneth Patrick Lorton | EVP CTO COO Software | 2026-02-10 | 925 | $13.73 | $12.70kSell |
| Robert Lorne Abel | EVP Chief Scientific Officer Platform | 2026-02-09 | 1,230 | $13.51 | $16.62kSell |
| Margaret Dugan | Chief Medical Officer | 2025-10-16 | 1,395 | $21.07 | $29.39kSell |
| Karen Akinsanya | President of RD Therapeutics | 2025-04-14 | 3,345 | $25.00 | $83.63kSell |
| Karen Akinsanya | President of RD Therapeutics | 2025-04-14 | 13,378 | $3.22 | $43.08kBuy |
| Karen Akinsanya | President of RD Therapeutics | 2025-04-14 | 8,378 | $25.11 | $210.39kSell |
| Karen Akinsanya | President of RD Therapeutics | 2025-04-14 | 3,345 | $2.92 | $9.77kBuy |
| Karen Akinsanya | President of RD Therapeutics | 2025-04-14 | 5,000 | $25.11 | $125.56kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 12.92% | 9,517,096 | $108.49M | Institution |
| Melinda Gates Foundation Trust Bill | 9.48% | 6,981,664 | $79.59M | Insider |
| Vanguard Group Inc | 8.78% | 6,464,426 | $73.69M | Institution |
| David E. Shaw | 8.41% | 6,196,609 | $70.64M | Insider |
| Sumitomo Mitsui Trust Group Inc | 6.40% | 4,714,767 | $53.75M | Institution |
| Rubric Capital Management LP | 5.66% | 4,171,498 | $47.56M | Institution |
| Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC | 5.05% | 3,717,890 | $42.38M | Institution |
| Amova Asset Management Americas Inc | 3.83% | 2,819,670 | $32.14M | Institution |
| Massachusetts Financial Services Co | 3.11% | 2,291,349 | $26.12M | Institution |
| Stephens Investment Management Group LLC | 3.05% | 2,250,098 | $25.65M | Institution |